A retrospective study investigating efficacy and safety of sofosbuvir based antiviral therapy in hepatitis C virus patients with severe renal failure

Trial Profile

A retrospective study investigating efficacy and safety of sofosbuvir based antiviral therapy in hepatitis C virus patients with severe renal failure

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Dec 2016

At a glance

  • Drugs Sofosbuvir (Primary) ; Daclatasvir; Peginterferon alfa-2a; Peginterferon alfa-2b; Peginterferon beta-1a; Ribavirin; Simeprevir
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Dec 2016 New trial record
    • 19 Oct 2016 Results published in the Nephrology Dialysis Transplantation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top